Drugwatch

Legal help for drug & device injuries. Est. 2009. Brought to you by The Wilson Firm LLP. Free case reviews. $324M+ won for clients.

[Drugwatch @Drug_watch]

The potential $7.25 billion Roundup settlement is heading back to state court

A federal judge on Wednesday sent the case back to Missouri court, which is Bayer’s preferred venue

Find out what this means for people who may be impacted by the settlement

https://t.co/86CXhO9SCC

[Drugwatch @Drug_watch]

In a major development, a global settlement agreement has been reached in the Depo-Provera MDL.

Terms still need to be finalized, but it could resolve thousands of lawsuits claiming that the popular birth control shot is tied to brain tumors.

https://t.co/R5JLz66zkb

[Drugwatch @Drug_watch]

Lawsuits claiming that Dupixent is tied to a rare form of cancer have been cleared to be consolidated into a federal MDL.

Find out what this big step forward means for the future of these growing lawsuits.

https://t.co/jd7Mg9dag0

[Drugwatch @Drug_watch]

The Roundup lawsuits are at a key juncture.

The fate of a $7.25 billion settlement that could resolve thousands of cancer lawsuits involving the popular weed killer is currently up in the air.

Catch up on the latest updates to this critical litigation.

https://t.co/p7cqeh99Br

[Drugwatch @Drug_watch]

In a major step forward, a group of spinal cord stimulator lawsuits will be grouped together in a new federal MDL.

But not all types of stimulators will be included. Learn more about the JPML’s decision and which cases are impacted.

https://t.co/Ueblill0dz

[The New Lede @thenewledenews]

A federal judge called @Bayer's proposed Roundup settlement a "filthy" deal.

Our Editor-in-Chief @careygillam spoke with attorney Whitney Di Bona from @Drug_watch about a flurry of recent legal maneuvers in the case.

[Drugwatch @Drug_watch]

@LaurenMedlicott Hey Lauren! Our PR Coordinator, Cheyenne, should have reached out to you with info for this.

[Drugwatch @Drug_watch]

Social Media Addiction: How is it rewiring your brain?

Drugwatch's Michelle Llamas shares important information with @LisaEvers and others on @fox5ny Street Soldiers https://t.co/CDEUiv13u5 via @YouTube

[Drugwatch @Drug_watch]

A decade ago, we exposed how the FDA was failing to protect women’s health. We followed up to see what’s changed.
The answer: not much.

Read the full investigation: https://t.co/5IXMJ249Ze

#WomensHealth #Accountability #FDA #Drugwatch

[Health Transformation Alliance @HTACOOP]

On the last episode of @Drug_watch's “Beyond the Scale: The Ozempic Effect” series, our CEO Rob Andrews shares his thoughts on the future of GLP-1 drugs explaining how Medicare must adopt value-based pricing to ensure cost-effective access.
🎧Listen now: https://t.co/BA7GsJIxEl

[Health Transformation Alliance @HTACOOP]

As demand surges for off-label and unregulated compounded versions of GLP-1 drugs, our CEO Rob Andrews raises alarms about the FDA’s limited oversight of compounding pharmacies on @Drug_watch's "Beyond the Scale: The Ozempic Effect” podcast.
🎧https://t.co/8BQzQ3V3iP

[Health Transformation Alliance @HTACOOP]

With many Americans unable to afford GLP-1 drugs, our CEO Rob Andrews spoke with Terry Turner & Christian Simmons, hosts of the “Beyond the Scale: The Ozempic Effect” podcast by @Drug_watch to explain what it would take to bring prices down.

🎧Listen now: https://t.co/jVPGD6qju4

[Health Transformation Alliance @HTACOOP]

Our CEO Rob Andrews talked with @TerryTurner_LT at @Drug_watch for their new podcast series and his insights were included in an article on how #GLP1 drugs have changed the treatment landscape for #diabetes and #obesity.

👉Read more and listen here:
https://t.co/BQTz6oajVw
#HTA

[Drugwatch @Drug_watch]

A Philadelphia jury ruled for Monsanto, finding the company not responsible for a woman’s cancer linked to Roundup. This adds to the mixed outcomes in lawsuits, as Bayer pushes for the Supreme Court to resolve ongoing legal disputes over the weed killer. https://t.co/aabHTLLPE0

[Drugwatch @Drug_watch]

Judge Nicholas G. Garaufis advanced federal Exactech litigation by setting preliminary trial dates for the third and fourth bellwether cases to start in October 2024 and January 2025: https://t.co/Cr0cXgHQAp

[Drugwatch @Drug_watch]

May 31 is #WorldNoTobaccoDay. The World Health Organization aims to raise awareness on tobacco risks. Many switch to e-cigarettes as a safer option, but they still contain addictive nicotine. Learn more about vaping risks: https://t.co/uZrCViU4wM

[Drugwatch @Drug_watch]

Today is #WorldDigestiveHealthDay and we're participating in raising awareness
about digestive disorders and maintaining good digestive health. Learn more about digestive diseases and tips for a healthy gut here: https://t.co/aN3Ctpq2Qo

[Drugwatch @Drug_watch]

We're taking a moment here at Drugwatch to pay tribute to the courageous individuals who gave their lives serving the nation. This #MemorialDay, we honor their legacy with gratitude for their valor.

[Drugwatch @Drug_watch]

Exactech issued a recall for specific Equinoxe Shoulder System joint replacement devices due to potential health risks stemming from defective packaging used between 2004 and August 2021. https://t.co/gnMqAytSek

[Drugwatch @Drug_watch]

Today, we're sharing the story of Michele Lynn, a loving wife and mom who lost her battle with breast cancer after using chemical hair relaxers for years. Her story shows why it's important for companies to warn about their products' risks. https://t.co/ENGAY9N5gJ